<DOC>
	<DOCNO>NCT00990600</DOCNO>
	<brief_summary>Primary objective study : To verify simplification antiretroviral regimen , measure reduction pill burden alone , may affect adherence rate patient .</brief_summary>
	<brief_title>QoL Adherence One-pill Once-a-day HAART</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Age &gt; 18 year Informed consent sign Effective ongoing treatment ( HIVRNA &lt; 50 copies/ml ) least three month Being stable HAART regimen base either two possible drug association : 3TC/FTC + TDF + EFV FTC/TDF ( fix dose combination ) + EFV No previous document virologic failure Childbearing breastfeeding . Women childbearing potential ask adopt effective contraceptive method behaviours Any ongoing grade 4 laboratory abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>adherence</keyword>
	<keyword>Qol</keyword>
	<keyword>virologic efficacy</keyword>
	<keyword>immunologic efficacy</keyword>
	<keyword>patient ' preference</keyword>
	<keyword>once-daily</keyword>
	<keyword>HAART</keyword>
	<keyword>treatment experience</keyword>
</DOC>